Comparative efficacy and safety of antidiabetic agents for post-transplant diabetes mellitus: a network meta-analysis
Insulin and SGLT2i represent the most efficacious and safest options among antidiabetic treatments for PTDM, supporting their preferential consideration in post-transplant diabetes management. Further large-scale, head-to-head trials are warranted to strengthen these findings.
Authors
- Shanbiao Hu (ORCID: https://orcid.org/0000-0002-1520-9531)
- Gongbin Lan (ORCID: https://orcid.org/0000-0001-6500-5820)
Institutions
- Central South University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fmed.2025.1653147
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29